Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Large turnout at hearing on 340B drug pricing bill; industry and safety‑net providers clash
Summary
The committee heard hours of testimony on HB 21‑45, a bill intended to protect 340B savings for safety‑net providers. Drugmakers and employer groups warned of increased costs and lost rebates; safety‑net hospitals and community health centers said the 340B program supports uncompensated care and essential services.
A lengthy, often contentious hearing focused on substitute House Bill 21‑45, which would protect covered entities’ access to 340B pricing and limit manufacturer or third‑party restrictions on contract pharmacies. The committee’s nonpartisan staff outlined the program background and the bill’s reporting and enforcement provisions, then reviewed fiscal notes reflecting potential administrative costs at the Department of Health and other agencies.
The hearing drew voices from across the health‑care spectrum. Hospital…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
